Variant report
Variant | nsv442074 |
---|---|
Chromosome Location | chr7:100329244-100332842 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:183)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr7:100329480-100329513 | GM13976 | blood: | n/a | n/a |
2 | PAX5 | chr7:100329892-100330334 | GM12891 | blood: | n/a | n/a |
3 | POLR2A | chr7:100331776-100331843 | K562 | blood: | n/a | n/a |
4 | POLR2A | chr7:100329481-100329606 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | POLR2A | chr7:100329493-100329614 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | SP1 | chr7:100329335-100329646 | HepG2 | liver: | n/a | n/a |
7 | ZNF384 | chr7:100330766-100330914 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:100330587-100330637 | GM12892 | blood: | n/a |
2 | chr7:100330872-100330922 | SK-N-SH | brain: | n/a |
3 | chr7:100330872-100330922 | K562 | blood: | n/a |
4 | chr7:100330587-100330637 | SK-N-MC | brain: | n/a |
5 | chr7:100330872-100330922 | HMEC | breast: | n/a |
6 | chr7:100330587-100330637 | GM19239 | blood: | n/a |
7 | chr7:100330587-100330637 | AG09309 | skin: | n/a |
8 | chr7:100330872-100330922 | ECC-1 | luminal epithelium: | n/a |
9 | chr7:100330109-100330159 | HPAEpiC | pulmonary alveolar: | n/a |
10 | chr7:100330872-100330922 | MCF10A-Er-Src | breast: | n/a |
11 | chr7:100330587-100330637 | CMK | blood: | n/a |
12 | chr7:100330872-100330922 | NHBE | bronchial: | n/a |
13 | chr7:100330872-100330922 | Jurkat | blood: | n/a |
14 | chr7:100330109-100330159 | ProgFib | skin: | n/a |
15 | chr7:100330109-100330159 | AoSMC | blood vessel: | n/a |
16 | chr7:100330109-100330159 | HRCEpiC | kidney: | n/a |
17 | chr7:100330109-100330159 | HCM | heart: | n/a |
18 | chr7:100330872-100330922 | H1-hESC | embryonic stem cell: | embryo |
19 | chr7:100330872-100330922 | AoSMC | blood vessel: | n/a |
20 | chr7:100330872-100330922 | AG09319 | gingival: | n/a |
21 | chr7:100330872-100330922 | HRPEpiC | eye: | n/a |
22 | chr7:100330872-100330922 | A549 | lung: | n/a |
23 | chr7:100330872-100330922 | HNPCEpiC | eye: | n/a |
24 | chr7:100330109-100330159 | RPTEC | kidney: | n/a |
25 | chr7:100330109-100330159 | PFSK-1 | brain: | n/a |
26 | chr7:100330109-100330159 | CMK | blood: | n/a |
27 | chr7:100330872-100330922 | HL-60 | blood: | n/a |
28 | chr7:100330109-100330159 | HMEC | breast: | n/a |
29 | chr7:100330109-100330159 | NB4 | blood: | n/a |
30 | chr7:100330587-100330637 | BJ | skin: | n/a |
31 | chr7:100330587-100330637 | AG04449 | skin: | fetal |
32 | chr7:100330587-100330637 | ECC-1 | luminal epithelium: | n/a |
33 | chr7:100330587-100330637 | GM12878 | blood: | n/a |
34 | chr7:100330587-100330637 | PFSK-1 | brain: | n/a |
35 | chr7:100330587-100330637 | HRPEpiC | eye: | n/a |
36 | chr7:100330872-100330922 | SAEC | small airway: | n/a |
37 | chr7:100330587-100330637 | AG09319 | gingival: | n/a |
38 | chr7:100330109-100330159 | HNPCEpiC | eye: | n/a |
39 | chr7:100330587-100330637 | AoSMC | blood vessel: | n/a |
40 | chr7:100330872-100330922 | RPTEC | kidney: | n/a |
41 | chr7:100330109-100330159 | SAEC | small airway: | n/a |
42 | chr7:100330587-100330637 | SKMC | muscle: | n/a |
43 | chr7:100330587-100330637 | NT2-D1 | testis: | n/a |
44 | chr7:100330109-100330159 | HIPEpiC | eye: | n/a |
45 | chr7:100330587-100330637 | MCF-7 | breast: | n/a |
46 | chr7:100330109-100330159 | Jurkat | blood: | n/a |
47 | chr7:100330109-100330159 | A549 | lung: | n/a |
48 | chr7:100330872-100330922 | GM19239 | blood: | n/a |
49 | chr7:100330109-100330159 | HAEpiC | amniotic membrane: | n/a |
50 | chr7:100330872-100330922 | BJ | skin: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZAN | TF binding region |
ZAN | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529130372 | chr7:100329259-100329260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200782533 | chr7:100329360-100329361 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs138330523 | chr7:100329402-100329403 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs562658608 | chr7:100329530-100329531 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs2406257 | chr7:100329567-100329568 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs373473786 | chr7:100329579-100329580 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs144073889 | chr7:100329601-100329602 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs142144640 | chr7:100329613-100329614 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs142859193 | chr7:100329614-100329615 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs370314239 | chr7:100329615-100329616 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs58927259 | chr7:100329617-100329618 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs199984017 | chr7:100329618-100329619 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs554315946 | chr7:100329733-100329734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527428013 | chr7:100329734-100329735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548976275 | chr7:100329784-100329785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71555297 | chr7:100329870-100329871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71555298 | chr7:100329873-100329874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs71555299 | chr7:100329876-100329877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs71555300 | chr7:100329891-100329892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71530304 | chr7:100329905-100329906 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs559512991 | chr7:100329920-100329921 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs115919587 | chr7:100329923-100329924 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs566106145 | chr7:100329931-100329932 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs550420989 | chr7:100329940-100329941 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs34146549 | chr7:100329977-100329978 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs397890265 | chr7:100329991-100329992 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs571850313 | chr7:100330038-100330039 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs376521161 | chr7:100330052-100330053 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs2406256 | chr7:100330091-100330092 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572205854 | chr7:100330111-100330112 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs75714327 | chr7:100330142-100330143 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs111796318 | chr7:100330298-100330299 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs187192107 | chr7:100330324-100330325 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs55867001 | chr7:100330325-100330326 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs191648750 | chr7:100330483-100330484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111338114 | chr7:100330492-100330493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562758934 | chr7:100330519-100330520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374394343 | chr7:100330586-100330587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184464349 | chr7:100330626-100330627 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs541066375 | chr7:100330648-100330649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564737635 | chr7:100330667-100330668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545218672 | chr7:100330679-100330680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559074751 | chr7:100330680-100330681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530900640 | chr7:100330841-100330842 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs144843407 | chr7:100330842-100330843 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs527363136 | chr7:100330866-100330867 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs188566621 | chr7:100330889-100330890 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs375845408 | chr7:100330890-100330891 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs560987370 | chr7:100330892-100330893 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531290631 | chr7:100330916-100330917 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 16608533 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Liver carcinoma | 19366792 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Breast cancer | 21858162 | CNVD |
Emphysema | 19352772 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 19401682 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 21509527 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Prostate cancer | 18632612 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:100319200-100342800 | Weak transcription | Right Atrium | heart |
2 | chr7:100323800-100334400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:100325400-100333000 | Weak transcription | Liver | Liver |
4 | chr7:100329200-100334400 | Enhancers | HepG2 | liver |
5 | chr7:100329600-100331000 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr7:100329600-100331200 | Enhancers | Primary B cells from cord blood | blood |
7 | chr7:100329800-100330600 | Enhancers | GM12878-XiMat | blood |
8 | chr7:100331400-100331800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr7:100331400-100331800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr7:100331400-100332000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr7:100331600-100332000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |